Craig Matturro
InvestorPrincipal at 1315 Capital · Investment Manager at Whiteoak
Philadelphia, Pennsylvania, United States
About
Craig Matturro joined 1315 Capital in 2016, having previously spent two years as an analyst in the investment banking group at Leerink Partners, where he worked on M&A and private placement engagements for healthcare companies. While at 1315 Capital he served on secondment as Director of Business Development for portfolio company JDS Therapeutics, leading the divestiture of its Nutrition21 division and the acquisition of nutraceutical assets by its Bonafide Health division. He holds a BSc in Business Administration with a concentration in Finance and a minor in Engineering Studies from Carnegie Mellon University.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Experience
- 1315 CapitalPrincipalcurrent2022 — present
- 1315 CapitalVice President2018 — 2022Greater Philadelphia
- 1315 CapitalAssociate2016 — 2018Greater Philadelphia
- Bonafide HealthDirector, Business Development2020 — 2022
- Nutrition21Director, Business Development2020 — 2021
- Leerink Partners LLCInvestment Banking Analyst2014 — 2016New York City Metropolitan Area
- Carnegie Mellon UniversitySupervisor2011 — 2014
- Leerink SwannSummer Banking Analyst2013
- First Empire SecuritiesSales and Trading Intern2012
Skills & more
+4 more
Public SpeakingEnglishEvent PlanningTime ManagementFrom Craig's professional profile.
Deals · 1
Spineology IncBoard seat
via 1315 Capital · filed Jun 2026 · $14.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Aluris SciencesCenturion Service GroupInnovative HealthOnkos SurgicalRestorative TherapiesSciSafeSolsys MedicalSpineologyTriple Ring Technologies
Investor
JDS Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at 1315 Capital
Frequently asked questions
- Who is Craig Matturro?
- Craig Matturro joined 1315 Capital in 2016, having previously spent two years as an analyst in the investment banking group at Leerink Partners, where he worked on M&A and private placement engagements for healthcare companies. While at 1315 Capital he served on secondment as Director of Business Development for portfolio company JDS Therapeutics, leading the divestiture of its Nutrition21 division and the acquisition of nutraceutical assets by its Bonafide Health division. He holds a BSc in Business Administration with a concentration in Finance and a minor in Engineering Studies from Carnegie Mellon University.
- Where does Craig Matturro work?
- Craig Matturro is Principal at 1315 Capital.
- What does Craig Matturro invest in?
- Craig Matturro invests in Biotech, Healthtech, Medical Devices.
- What boards does Craig Matturro sit on?
- Craig Matturro holds tracked board seats at Aluris Sciences, Centurion Service Group, Innovative Health, Onkos Surgical, Restorative Therapies, SciSafe, Solsys Medical, Spineology, Spineology Inc, Triple Ring Technologies.
- What companies has Craig Matturro invested in?
- Investments tracked here include JDS Therapeutics.
- Where did Craig Matturro go to school?
- Craig Matturro studied at Carnegie Mellon University (Bachelor of Science (BS), Business Administration).
Same school
Also attended Carnegie Mellon University528
+ 522 more
Shared employers
Also worked at 1315 Capital15
+ 9 more
Also worked at Bonafide Health1
Also worked at Nutrition211
Also worked at Carnegie Mellon University201
+ 195 more